Abstract
Background: Over 450 million people worldwide have a rare disease. Yet despite healthcare policy rhetoric placing an onus on inclusive public engagement, rare disease publics are often engaged as data sources or product/service consumers. Meanwhile, various rare disease actors congregate around ‘Rare Disease Day’ each year – a global event with various online and offline talks, workshops, and sessions. In 2021, ~4.3 million tweets marked Twitter as a locus of exchange for the event. Methods: To examine public discourse around the event, the paper draws on social network and qualitative analyses of 40,366 Twitter tweets/retweets about rare disease day 2021 posted between 10-Feb-2021 and 10-Mar-2021, analysing them through a controversy theory lens. After identifying particularly influential Twitter users and groups, the paper examines their textual and visual communication strategies. Results: It funds three distinct orientations to rare disease discourse on Twitter (mission, awareness, and actor). In doing so, the paper locates a gap in direct engagement between medical authority and patients. Conclusions: It suggests that each orientation towards the discourse around rare disease day 2021 might be used by policymakers and researchers to engage with rare disease publics on social media in a more inclusive way as a pathway to better healthcare provision.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference46 articles.
1. NHL players, local businesses help Kootenay man raise funds and awareness for rare genetic disease.;J Bailey;Trail Times.,2021
2. Supporting Rare Disease Drug Development: CDER’s Rare Diseases Program: 2017 Roadmap for Engaging with the Center for Drug Evaluation and Research;L Bauer,2017
3. Fast unfolding of communities in large networks.;V Blondel;J Stat Mech.,2008
4. Durkheim and Mauss revisited: Classification and the sociology of knowledge.;D Bloor;Stud Hist Philos Sci: Part A.,1982
5. BrainStorm Announces Topline Results from NurOwn® Phase 3 ALS Study,2020